Search

News October 2008
... open. Each award totals up to $80000 per year for up to 2 years. For more information about the Dr Brian D. Norris ...
News / BY: David R. Richardson, MD October 2008
... Peter Legge Management Co. Ltd., 2008. ISBN 978-0-9781459-2-7. Paperback, 272 pages. $29.95. To order, e-mail  ...
Letters / BY: Paul K.B. Dagg, MD, FRCPC, October 2008
... for the Interior Health Authority (IHA) for over 2 years, and for the Northern Health Authority (NHA) for the ...
Council on Health Promotion / BY: Lloyd Oppel, MD, MHSc, FCFP(Em) October 2008
... are owned by so-called big pharma. Canadians spend over $2 billion yearly on natural health products ranging from ...
BC Centre for Disease Control / BY: David M. Patrick, MD, FRCPC, MHSc October 2008
... health initiative in BC. Since its inception, 25000 grade 2 children, 5000 children in day care, and 6000 health care ...
Clinical Articles / BY: Nathan A. Hoag, BSc, October 2008
... • The benefits of screening outweigh the harms.[ 2 ]  In evaluating a population screening program, the ... screening, with sensitivities of 72.1% for PSA and 53.2% for DRE.[ 4 ] Used in combination, PSA and DRE remain the ... best available tools, with an estimated sensitivity of 87.2%.  In comparison, breast cancer screening with mammography ...
Clinical Articles / BY: Jason Andrade, MD, FRCPC, October 2008
... in the 2007 version of the ACC/AHA document ( Table 2 ) involve a shift toward recommending prophylaxis only for ... The patients who meet the criteria in part A of  Table 2  and are undergoing a procedure listed in part B should be ...
Clinical Articles / BY: Nupura Krishnadev, MD, October 2008
... to be associated with weight gain, dyslipidemia, and type 2 diabetes. These adverse effects act synergistically in ... disease than members of the general population.[ 2 ] Patients with schizophrenia are predisposed to obesity, type 2 diabetes, abnormal variations in cardiac rate, and sudden ...
WorkSafeBC / BY: Peter Rothfels, MD November 2008
... review or randomized controlled trial. • Level 2—Well-designed controlled trials or systematic review of ... to the treatment of chronic pain.  Pain Medicine. 2005;6(2):107-112 (evidence level 5)—Describes 10 steps of ...
Premise / BY: Marshall Dahl, MD, PhD, FRCPC November 2008
... outcomes in a subset of higher-risk people with type 2 diabetes. The ACCORD study is a multi-centre, randomized ... outcomes in a subset of higher-risk people with type 2 diabetes. On 6 February 2008, the National Heart, Lung and ... the implications of this study for the treatment of type 2 diabetes. BC’s Therapeutics Initiative (TI) published a ...